Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) released earnings for its first quarter that Increased, from the same period last year
The company's earnings came in at RMB423.80 million, or RMB0.55 per share. This compares with RMB374.25 million, or RMB0.49 per share, last year.
The company's revenue for the period rose 4.1% to RMB1.515 billion from RMB1.455 billion last year.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited earnings at a glance (GAAP) :
-Earnings: RMB423.80 Mln. vs. RMB374.25 Mln. last year.-EPS: RMB0.55 vs. RMB0.49 last year.-Revenue: RMB1.515 Bln vs. RMB1.455 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.